Combined elevation of pre-treatment γ-glutamyltransferase and lactate dehydrogenase as independent prognosticator for metastatic renal cell carcinoma undergoing immune-based therapy
{{output}}
In a preceding monocentric study, serum liver enzymes (ALAT, ASAT, GGT) and lactate dehydrogenase (LDH) were identified as independent prognosticators for patients with metastatic renal cell cancer (mRCC) treated with immune-based first-line (1L) therapy. Here... ...
